Controlling health expenditures--the Canadian reality

The New England Journal of Medicine
R G EvansG W Torrance

Abstract

Canada and the United States have conducted a large-scale social experiment on the effects of alternative ways of funding expenditures for health care. Two very similar societies, with (until recently) very similar systems of providing health care, have adopted radically different systems of reimbursement. The results of this experiment are of increasing interest to Americans, because the Canadian approach has avoided or solved several of the more intractable problems facing the United States. In particular, overall health expenditures have been constrained to a stable share of national income, and universality of coverage (without user charges) eliminates the problems of uncompensated care, individual burdens of catastrophic illness, and uninsured populations. The combination of cost control with universal, comprehensive coverage has surprised some American observers, who have questioned its reality, its sustainability, or both. We present a comparison of the Canadian and American data on expenditures, identifying the sectors in which the experience of the two nations diverges most, and describing the processes of control. In any system, cost control involves conflict between providers and payers. Political processes focus thi...Continue Reading

References

Jan 1, 1989·International Journal of Health Services : Planning, Administration, Evaluation·M L BarerJ Lomas
Feb 13, 1986·The New England Journal of Medicine·D U Himmelstein, S Woolhandler
Jul 17, 1986·The New England Journal of Medicine·J K Iglehart
Sep 18, 1986·The New England Journal of Medicine·J K Iglehart
Jan 1, 1986·Journal of Health Politics, Policy and Law·R G Evans
Apr 30, 1987·The New England Journal of Medicine·E Ginzberg
Jan 1, 1987·Health Affairs·G R Wilensky
Jan 1, 1988·Health Affairs·V R Fuchs
Jan 1, 1988·Health Affairs·J P NewhouseL L Roos
Jan 1, 1988·Health Affairs·R H Brook, J B Kosecoff
Oct 1, 1987·The New England Journal of Medicine·J FederS Zuckerman
Jan 1, 1988·Journal of Health Politics, Policy and Law·M L Barer
Dec 18, 1986·The New England Journal of Medicine·J K Iglehart
Jan 1, 1985·Journal of Health Politics, Policy and Law·J R Gabel, T H Rice
Jan 1, 1986·Medical Care·A S DetskyS R Stacey
Jul 21, 1983·The New England Journal of Medicine·A S DetskyC Bombardier

❮ Previous
Next ❯

Citations

Dec 1, 1990·Aging : Clinical and Experimental Research·R L Kane, R A Kane
May 1, 1996·Journal of the American College of Cardiology·J L CoxD E Johnstone
Jul 31, 1999·International Journal of Pediatric Otorhinolaryngology·P C CoyteL M Elden
Mar 8, 1998·Journal of Health Economics·L Di Matteo, R Di Matteo
Apr 1, 1997·Critical Care Clinics·W J Sibbald, T Singh
Jan 1, 1995·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·D D MillerR Taillefer
May 19, 2010·Health Economics, Policy, and Law·Gwyn BevanDavid Wilsford
Mar 2, 1989·The New England Journal of Medicine·A S Relman
Jul 6, 1989·The New England Journal of Medicine·J S Todd
Jul 13, 1989·The New England Journal of Medicine
Nov 30, 1989·The New England Journal of Medicine
Aug 23, 1990·The New England Journal of Medicine·A L Schorr
Sep 6, 1990·The New England Journal of Medicine·D E Beauchamp, R L Rouse
Sep 13, 1990·The New England Journal of Medicine
Nov 22, 1990·The New England Journal of Medicine·A L Linton, C D Naylor
Apr 11, 1991·The New England Journal of Medicine·E A Friedman
Feb 6, 1992·The New England Journal of Medicine·J M Colwill
Mar 18, 1993·The New England Journal of Medicine·D A Redelmeier, V R Fuchs
Apr 8, 1993·The New England Journal of Medicine·R J BlendonS W Levitt
Oct 20, 1994·The New England Journal of Medicine·P C CoyteE Ho
Jun 30, 2000·The New England Journal of Medicine·J K Iglehart
Apr 1, 1991·Hospital Topics·J S Rakick
Sep 1, 1993·Annals of Surgery·L D MacLean
Jun 1, 1995·Employee Benefits Journal·G A Mitchell
Mar 15, 1990·American Journal of Ophthalmology·J C Noreika
Jan 4, 1992·Healthcare Management Forum·S B ShepsK Cardiff
Nov 1, 1993·American Journal of Public Health·G J HayesT Dykstra
May 16, 2000·Cancer Investigation·F L MoffatW J Temple
Dec 10, 1990·Journal of Policy Analysis and Management : [the Journal of the Association for Public Policy Analysis and Management]·S Globerman
Nov 9, 2010·Health Policy·Jeffrey Che-Hung TsaiYia-Wun Liang
Apr 1, 1991·International Journal of Radiation Oncology, Biology, Physics·C A Perez
Nov 1, 1990·Gastrointestinal Endoscopy·M V Sivak
Jan 8, 1994·Health Policy·T Rathwell
Jun 8, 1991·Health Policy·D A Rublee, J W Moser

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.